Dr. L. Rohit Reddy is a well-known Consultant Medical Oncologist & Hemato Oncologist in Hyderabad. He received his education at the All India Institute of Medical Sciences in New Delhi, India’s top-ranked medical school, and completed his training under eminent professors and doctors. He previously received his training in internal medicine at Kasturba Medical College in Manipal, an esteemed medical facility in India.
Dr. L. Rohit Reddy is a pioneer in cancer research and an expert oncologist who specialises in the diagnosis, planning, management, and treatment of all cancers. He advocates for assisting cancer patients in leading fulfilling lives and prioritises patient communication as the most crucial component of cancer care.
Educational Qualifications
2019-2022: DM, Medical Oncology , All India Institute of Medical Sciences, New Delhi
2015-2018: MD, Internal Medicine, Kasturba Medical College, Manipal, Karnataka
2008-2014: MBBS, Kamineni Institute of Medical Sciences, Narketpally, Telangana
Experience
Jan 2019-Jan 2022: DM, Medical Oncology, All India Institute of Medical Sciences, New Delhi
May 2015- May 2018: MD, Internal Medicine, Kasturba Medical College, Manipal, Karnataka, India
April 2013-April 2014: Compulsory Rotatory Internship, Medical Internee, Gandhi Medical College, Secunderabad, India
Services offered
Diagnosing Cancer
Tumour Board
Hemato Oncology Services
Hematopoietic Stem Cell Transplant and Other Cellular Therapies
Won 1st Prize at Quiz Competition at National level at APICON, Mumbai, 2017
Received Scholarship Grants for participating in various International Meets such as Leukemia, Lymphoma and Myeloma Conference, New York, October 2021 (Scholarship Award) (Virtual), European Society of Medical Oncology, 2021 (International Cancer Foundation Grant) (Virtual), Society of Hematologic Oncology, Texas, USA, Sept 2021 (Young Investigator Program Travel Grant), European Hematologic Association, Annual Meet, July 2021 (Virtual), HOPE Asia, Sri Lanka, Asia, 2020
Recipient of YIP Travel Grant SOHO, Texas, USA, 2022
Recipient of Travel Grant for European Hematology Association, Annual Conference, Vienna, Austria, 2022
Member of American Society of Clinical Oncology (ASCO)
Member of European Society of Medical Oncology (ESMO)
Member of European Society of Hematology (EHA)
Member of Society of Hemato-Oncology, USA (SOHO)
Trainee Reviewer at Indian Journal of Medical and Paediatric Oncology (IJMPO)
Member of Indian Cooperative Oncology Network (ICON)
Nivalika R, Musugu JM, Reddy LR, Madhuvijay P, Ingle A. A Rare Case of Metaplastic Carcinoma of the Axillary Tail with Coexisting Extrapulmonary Liver Tuberculosis Mimicking a Solitary Liver Metastasis: A Diagnostic and Therapeutic Challenge. Indian Journal of Gynecologic Oncology. 2025 Dec;23(4):131.
Reddy, L.R., Kumar, L., Malik, P.S., Sahoo, R.K., Prasad, C. and Gupta, R., 2025. Management of Relapsed/Refractory Myeloma in Resource Constrained Setting: Median age (years) Age (Years) Immunoglobulin subtypeHb (G/dL) Serum creatinineeGFR mL/minuteSerum albumin (g/dL) Serum LDHPlatelets countsCirculating plasma cells CytogeneticsHypercalcemiaCo-morbiditiesDiabetesHypertensionHypothyroidismF/H of malignancy. Clinical Lymphoma Myeloma and Leukemia.
Hardy N, Vegivinti CT, Mehta M, Thurnham J, Mebane A, Pederson JM, Tarchand R, Shivakumar J, Olaniran P, Gadodia R, Ganguly A. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis. Clinical and Experimental Medicine. 2023 Oct;23(6):1945-59.
Tansir G, Rastogi S, Dubasi SK, Chitikela S, Reddy LR, Barwad A, Goyal A. Lessons learnt from the clinico-genomic profiling of families with Li Fraumeni syndrome at a tertiary care centre in North India. ecancermedicalscience. 2023 May 11;17:1550.
Sharma A, Reddy R, Pramanik R, Sahoo RK, Kaushal S, Haresh KP, Kumar S, Kumar L, Sharma A, Batra A. Primary mediastinal germ cell tumors (PMGCT): A real-world analysis from A tertiary cancer care center in India. Cancer Investigation. 2023 May 28;41(5):467-73.
Reddy LR, Kumar L, Veligapudi RM, Konda S. MM-252 A Retrospective Review of Relapsed Multiple Myeloma Post Autologous Stem Cell Transplant: Data From an Indian Tertiary Cancer Center. Clinical Lymphoma Myeloma and Leukemia. 2022 Oct 1;22:S416. (SOHO Texas 2022)
Reddy R, Velagapudi RM, Chitikela SD, Barwad A, Shrivastava S, Dhamija E, Shamim SA, Tripathy S, Pandey R, Rastogi S. Indian experience with immunotherapy in sarcoma and gastrointestinal stromal tumors: a retrospective study. Future Science OA. 2022 Jun 1;8(5):FSO795.
Lavu RR, Kumar L, Konda S, Velagapudi RM. PB2010: RETROSPECTIVE STUDY OF RELAPSED/REFRACTORY MYELOMA PATIENTS FROM AN INDIAN TERTIARY CENTRE: RESPONSE MATTERS!!. HemaSphere. 2022 Jun 1;6:1881-2. (EHA. Vienna, 2022 )
Reddy LR, Rasheed AA, Rastogi S. The evolving role of precision medicine in the management of advanced sarcomas–A mini review. International Journal of Molecular and Immuno Oncology. 2021 Sep 27;6(3):122-31.
Sharma A, Biswas B, Reddy R, Thumbudorai R, Ganguly S, Dabkara D, Pramanik R, Kumar S, Sahoo RK, Sharma A, Kumar L. Seminomatous and Non-Seminomatous Mediastinal Germ Cell Tumors (MGCT): A Real-World Analysis from two Tertiary Care Centers in India.
Verma S, Reddy R, Chandrashekhara SH, Shamim SA, Tripathy S, Rastogi S. Avapritinib in Advanced Gastrointestinal Stromal Tumor: Case Series and Review of the Literature from a Tertiary Care Center in India. Future Science OA. 2020 Dec(0):FSO676.
Varma M, Reddy LR, Vidyasagar S, Holla A, Bhat NK. Risk Factors for Carbapenem Resistant Enterobacteriaceae in a Teritiary Hospital-A Case Control Study. Indian Journal Of Medical Specialities. 2018 Oct 1;9(4):178-83.
Weber SF, Bélard S, Rai S, Reddy R, Belurkar S, Saravu K. Immune Thrombocytopenia Secondary to Tuberculosis: A Case and Review of Literature. The International Journal of Tuberculosis and Lung Disease. 2017 Apr 1;21(4):466-70.
Bhat N, Vidyasagar S, Reddy R, Holla A. Ranitidine Induced Anaphylaxis. APIK Journal of Internal Medicine. 2016 Jul 1;4(3):36.
Thesis on “Prognostic Factors and Outcomes of Relapsed Multiple Myeloma treated with Antibody Free Regimes in an Indian Scenario” At AIIMS, Delhi under guidance of Padma Shri, Dr. Lalit Kumar
Research Project on “Comparison of outcomes between Biochemical Relapse and Clinical Relapse when treated with IMiD-based Triplet”
Risk Factors and outcomes of Carbapenem Resistant Enterobacteriaceae-A Case Control Study, Thesis Project At KMC, Manipal under guidance of Dr. Muralidhar Verma
Other Scientific Activities
Poster: MM-257: It’s the Response That Matters: Real-World Data of Multiple Myeloma Patients Treated without Upfront Stem Cell Transplant Lavu, Rohit Reddy et al. Clinical Lymphoma, Myeloma and Leukemia, Volume 21, S255-Presented at SOHO, Texas, 2021
Seminomatous and Non-Seminomatous Mediastinal Germ Cell Tumors (MGCT): A Real-World Analysis from two Tertiary Care Centers in India. Aparna Sharma, Bivas Biswas, Rohit Reddy, Robin Thumbudorai, Sandip Ganguly, Deepak Dabkara, Raja Pramanik, Sunil Kumar, Ranjit Kumar Sahoo, Atul Sharma, Lalit Kumar, and Atul Batra, Journal of Clinical Oncology 2021 39:15_suppl, e18726-e18726- e abstract ASCO 2021
Oral Presentation No. – O-6, titled “Indian Experience with Immunotherapy in Sarcoma and GIST: A Retrospective Study" at IMSOS, India, 2021.
Appointment
Second Opinion
Live Chat
Call
More
